CH EPL (R5)
0.1.0 - ci-build
CH EPL (R5)
0.1.0 - ci-build
CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions
<Bundle xmlns="http://hl7.org/fhir">
<id value="08f553cb-1404-4972-bf14-2023a5f59955"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-bundle"/>
</meta>
<type value="collection"/>
<entry>
<fullUrl
value="http://example.org/MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet"/>
<resource>
<MedicinalProductDefinition>
<id value="Cuprior-150mg-Filmcoatedtablet"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-medicinalproductdefinition"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicinalProductDefinition_Cuprior-150mg-Filmcoatedtablet"> </a><p class="res-header-id"><b>Generated Narrative: MedicinalProductDefinition Cuprior-150mg-Filmcoatedtablet</b></p><a name="Cuprior-150mg-Filmcoatedtablet"> </a><a name="hcCuprior-150mg-Filmcoatedtablet"> </a><a name="Cuprior-150mg-Filmcoatedtablet-en-US"> </a><p><b>CH - SMC Authorized Dose Form</b>: <span title="Codes:{urn:oid:0.4.0.127.0.16.1.1.2.1 10221000}">Film-coated tablet</span></p><p><b>CH - EPL Full Limitation Text</b>: CUPRIOR wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden.</p><p><b>identifier</b>: <code>http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID</code>/CH-7640109110007-6771901</p><p><b>domain</b>: <span title="Codes:{urn:oid:1.2.276.0.76 100000000012}">Human</span></p><p><b>indication</b>: </p><div><p>Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie.</p>
</div><p><b>legalStatusOfSupply</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply 756005022003}">Abgabe auf ärztliche oder tierärztliche Verschreibung (B)</span></p><p><b>classification</b>: <span title="Codes:{http://www.whocc.no/atc L01EX13}">gilteritinib</span>, <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-therapeuticproductcode S}">Synthetika</span></p><p><b>attachedDocument</b>: </p><ul><li><a href="DocumentReference-DocRef-FI-Cuprior.html">DocumentReference: status = current; type = Fachinformation</a></li><li><a href="DocumentReference-DocRef-PI-Cuprior.html">DocumentReference: status = current; type = Patienteninformation</a></li></ul><blockquote><p><b>name</b></p><p><b>productName</b>: Cuprior 150 mg, Filmtabletten</p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-medicinal-product-name-type SMC}">Swissmedic</span></p><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{urn:iso:std:iso:3166 CH}">Switzerland</span></td><td><span title="Codes:{urn:ietf:bcp:47 de-CH}">German (Switzerland)</span></td></tr></table></blockquote></div>
</text>
<extension
url="http://fhir.ch/ig/ch-epl/StructureDefinition/authorizedDoseForm">
<valueCodeableConcept>
<coding>
<system value="urn:oid:0.4.0.127.0.16.1.1.2.1"/>
<code value="10221000"/>
<display value="Film-coated tablet"/>
</coding>
</valueCodeableConcept>
</extension>
<extension
url="http://fhir.ch/ig/ch-epl/StructureDefinition/fullLimitationText">
<valueString
value="CUPRIOR wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden."/>
</extension>
<identifier>
<system
value="http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID"/>
<value value="CH-7640109110007-6771901"/>
</identifier>
<domain>
<coding>
<system value="urn:oid:1.2.276.0.76"/>
<code value="100000000012"/>
<display value="Human"/>
</coding>
</domain>
<indication
value="Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie."/>
<legalStatusOfSupply>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply"/>
<code value="756005022003"/>
<display
value="Abgabe auf ärztliche oder tierärztliche Verschreibung (B)"/>
</coding>
</legalStatusOfSupply>
<classification>
<coding>
<system value="http://www.whocc.no/atc"/>
<code value="L01EX13"/>
</coding>
</classification>
<classification>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-therapeuticproductcode"/>
<code value="S"/>
<display value="Synthetika"/>
</coding>
</classification>
<attachedDocument>🔗
<reference value="DocumentReference/DocRef-FI-Cuprior"/>
</attachedDocument>
<attachedDocument>🔗
<reference value="DocumentReference/DocRef-PI-Cuprior"/>
</attachedDocument>
<name>
<productName value="Cuprior 150 mg, Filmtabletten"/>
<type>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-medicinal-product-name-type"/>
<code value="SMC"/>
<display value="Swissmedic"/>
</coding>
</type>
<usage>
<country>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="CH"/>
<display value="Switzerland"/>
</coding>
</country>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="de-CH"/>
<display value="German (Switzerland)"/>
</coding>
</language>
</usage>
</name>
</MedicinalProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="http://example.org/DocumentReference/DocRef-FI-Cuprior"/>
<resource>
<DocumentReference>
<id value="DocRef-FI-Cuprior"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-documentreference"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="DocumentReference_DocRef-FI-Cuprior"> </a><p class="res-header-id"><b>Generated Narrative: DocumentReference DocRef-FI-Cuprior</b></p><a name="DocRef-FI-Cuprior"> </a><a name="hcDocRef-FI-Cuprior"> </a><a name="DocRef-FI-Cuprior-en-US"> </a><p><b>status</b>: Current</p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-attached-document-type FI}">Fachinformation</span></p><blockquote><p><b>content</b></p><h3>Attachments</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Url</b></td></tr><tr><td style="display: none">*</td><td><a href="https://swissmedicinfo.ch/showText.aspx?textType=FI&lang=DE&authNr=67719&supportMultipleResults=1">https://swissmedicinfo.ch/showText.aspx?textType=FI&lang=DE&authNr=67719&supportMultipleResults=1</a></td></tr></table></blockquote></div>
</text>
<status value="current"/>
<type>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-attached-document-type"/>
<code value="FI"/>
<display value="Fachinformation"/>
</coding>
</type>
<content>
<attachment>
<url
value="https://swissmedicinfo.ch/showText.aspx?textType=FI&lang=DE&authNr=67719&supportMultipleResults=1"/>
</attachment>
</content>
</DocumentReference>
</resource>
</entry>
<entry>
<fullUrl value="http://example.org/DocumentReference/DocRef-PI-Cuprior"/>
<resource>
<DocumentReference>
<id value="DocRef-PI-Cuprior"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-documentreference"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="DocumentReference_DocRef-PI-Cuprior"> </a><p class="res-header-id"><b>Generated Narrative: DocumentReference DocRef-PI-Cuprior</b></p><a name="DocRef-PI-Cuprior"> </a><a name="hcDocRef-PI-Cuprior"> </a><a name="DocRef-PI-Cuprior-en-US"> </a><p><b>status</b>: Current</p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-attached-document-type PI}">Patienteninformation</span></p><blockquote><p><b>content</b></p><h3>Attachments</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Url</b></td></tr><tr><td style="display: none">*</td><td><a href="https://swissmedicinfo.ch/showText.aspx?textType=PI&lang=DE&authNr=67719&supportMultipleResults=1">https://swissmedicinfo.ch/showText.aspx?textType=PI&lang=DE&authNr=67719&supportMultipleResults=1</a></td></tr></table></blockquote></div>
</text>
<status value="current"/>
<type>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-attached-document-type"/>
<code value="PI"/>
<display value="Patienteninformation"/>
</coding>
</type>
<content>
<attachment>
<url
value="https://swissmedicinfo.ch/showText.aspx?textType=PI&lang=DE&authNr=67719&supportMultipleResults=1"/>
</attachment>
</content>
</DocumentReference>
</resource>
</entry>
<entry>
<fullUrl value="http://example.org/RegulatedAuthorisation/MA-6771901"/>
<resource>
<RegulatedAuthorization>
<id value="MA-6771901"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-regulatedauthorization"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_MA-6771901"> </a><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization MA-6771901</b></p><a name="MA-6771901"> </a><a name="hcMA-6771901"> </a><a name="MA-6771901-en-US"> </a><p><b>identifier</b>: <code>http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MarketingAuthorisationNumber</code>/6771901</p><p><b>subject</b>: <a href="MedicinalProductDefinition-Cuprior-150mg-Filmcoatedtablet.html">MedicinalProductDefinition: extension = Film-coated tablet,CUPRIOR wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden.; identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID#CH-7640109110007-6771901; domain = Human; indication = Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie.; legalStatusOfSupply = Abgabe auf ärztliche oder tierärztliche Verschreibung (B); classification = gilteritinib,Synthetika</a></p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type 756000002001}">Marketing Authorisation</span></p><p><b>region</b>: <span title="Codes:{urn:iso:std:iso:3166 CH}">Switzerland</span></p><p><b>status</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status Z}">zugelassen</span></p><p><b>statusDate</b>: 2021-01-21</p><p><b>holder</b>: <a href="#hcMA-6771901/holder-Curatis-AG">Organization Curatis AG</a></p><p><b>regulator</b>: <a href="#hcMA-6771901/regulator-SMC">Organization SMC</a></p><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #holder-Curatis-AG</b></p><a name="MA-6771901/holder-Curatis-AG"> </a><a name="hcMA-6771901/holder-Curatis-AG"> </a><a name="MA-6771901/holder-Curatis-AG-en-US"> </a><p><b>identifier</b>: <code>urn:oid:1.2.276.0.76</code>/100082791, <a href="https://www.gs1.org/standards/id-keys/gln" title="Global Location Number">GLN</a>/7640109110007</p><p><b>name</b>: Curatis AG</p></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #regulator-SMC</b></p><a name="MA-6771901/regulator-SMC"> </a><a name="hcMA-6771901/regulator-SMC"> </a><a name="MA-6771901/regulator-SMC-en-US"> </a><p><b>identifier</b>: <code>urn:oid:1.2.276.0.76</code>/100010911, <a href="https://www.gs1.org/standards/id-keys/gln" title="Global Location Number">GLN</a>/7601001398511</p><p><b>name</b>: SMC</p></blockquote></div>
</text>
<contained>
<Organization>
<id value="holder-Curatis-AG"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-epl-organization"/>
</meta>
<identifier>
<system value="urn:oid:1.2.276.0.76"/>
<value value="100082791"/>
</identifier>
<identifier>
<system value="urn:oid:2.51.1.3"/>
<value value="7640109110007"/>
</identifier>
<name value="Curatis AG"/>
</Organization>
</contained>
<contained>
<Organization>
<id value="regulator-SMC"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-epl-organization"/>
</meta>
<identifier>
<system value="urn:oid:1.2.276.0.76"/>
<value value="100010911"/>
</identifier>
<identifier>
<system value="urn:oid:2.51.1.3"/>
<value value="7601001398511"/>
</identifier>
<name value="SMC"/>
</Organization>
</contained>
<identifier>
<system
value="http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MarketingAuthorisationNumber"/>
<value value="6771901"/>
</identifier>
<subject>🔗
<reference
value="MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet"/>
</subject>
<type>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type"/>
<code value="756000002001"/>
<display value="Marketing Authorisation"/>
</coding>
</type>
<region>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="CH"/>
<display value="Switzerland"/>
</coding>
</region>
<status>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status"/>
<code value="Z"/>
<display value="zugelassen"/>
</coding>
</status>
<statusDate value="2021-01-21"/>
<holder>
<reference value="#holder-Curatis-AG"/>
</holder>
<regulator>
<reference value="#regulator-SMC"/>
</regulator>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl
value="http://example.org/PackagedProductDefinition/PMP-Cuprior-150mg-Filmcoatedtablet"/>
<resource>
<PackagedProductDefinition>
<id value="PMP-Cuprior-150mg-Filmcoatedtablet"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-packagedproductdefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_PMP-Cuprior-150mg-Filmcoatedtablet"> </a><p class="res-header-id"><b>Generated Narrative: PackagedProductDefinition PMP-Cuprior-150mg-Filmcoatedtablet</b></p><a name="PMP-Cuprior-150mg-Filmcoatedtablet"> </a><a name="hcPMP-Cuprior-150mg-Filmcoatedtablet"> </a><a name="PMP-Cuprior-150mg-Filmcoatedtablet-en-US"> </a><p><b>identifier</b>: <code>http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-PCID</code>/CH-7640109110007-6771901-001</p><p><b>packageFor</b>: <a href="MedicinalProductDefinition-Cuprior-150mg-Filmcoatedtablet.html">MedicinalProductDefinition: extension = Film-coated tablet,CUPRIOR wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden.; identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID#CH-7640109110007-6771901; domain = Human; indication = Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie.; legalStatusOfSupply = Abgabe auf ärztliche oder tierärztliche Verschreibung (B); classification = gilteritinib,Synthetika</a></p><p><b>description</b>: </p><div><p>CUPRIOR Filmtabl 150 mg 72 Stk</p>
</div><h3>LegalStatusOfSupplies</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply 756005022003}">Abgabe auf ärztliche oder tierärztliche Verschreibung (B)</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>identifier</b>: <code>urn:oid:2.51.1.1</code>/7680677190018</p><p><b>type</b>: <span title="Codes:{urn:oid:0.4.0.127.0.16.1.1.2.1 30009000}">Box</span></p><p><b>quantity</b>: 1</p><h3>ShelfLifeStorages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Period[x]</b></td><td><b>SpecialPrecautionsForStorage</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{urn:oid:1.2.276.0.76 100000073403}">Shelf life of the medicinal product as packaged for sale</span></td><td>No display for Duration (value: 36; unit: month; system: http://unitsofmeasure.org; code: mo)</td><td><span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-special-precautions-for-storage NO30}">Nicht über 30°C</span></td></tr></table></blockquote><h3>Characteristics</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Value[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-product-characteristics-type PackageItemContainer}">Other Characteristics</span></td><td><span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-other-characteristics-packaged-item 756005041001}">Modal-Packung</span></td></tr></table></div>
</text>
<identifier>
<system
value="http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-PCID"/>
<value value="CH-7640109110007-6771901-001"/>
</identifier>
<packageFor>🔗
<reference
value="MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet"/>
</packageFor>
<description value="CUPRIOR Filmtabl 150 mg 72 Stk"/>
<legalStatusOfSupply>
<code>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply"/>
<code value="756005022003"/>
<display
value="Abgabe auf ärztliche oder tierärztliche Verschreibung (B)"/>
</coding>
</code>
</legalStatusOfSupply>
<packaging>
<identifier>
<system value="urn:oid:2.51.1.1"/>
<value value="7680677190018"/>
</identifier>
<type>
<coding>
<system value="urn:oid:0.4.0.127.0.16.1.1.2.1"/>
<code value="30009000"/>
<display value="Box"/>
</coding>
</type>
<quantity value="1"/>
<shelfLifeStorage>
<type>
<coding>
<system value="urn:oid:1.2.276.0.76"/>
<code value="100000073403"/>
<display
value="Shelf life of the medicinal product as packaged for sale"/>
</coding>
</type>
<periodDuration>
<value value="36"/>
<unit value="month"/>
<system value="http://unitsofmeasure.org"/>
<code value="mo"/>
</periodDuration>
<specialPrecautionsForStorage>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-special-precautions-for-storage"/>
<code value="NO30"/>
<display value="Nicht über 30°C"/>
</coding>
</specialPrecautionsForStorage>
</shelfLifeStorage>
</packaging>
<characteristic>
<type>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-product-characteristics-type"/>
<code value="PackageItemContainer"/>
<display value="Other Characteristics"/>
</coding>
</type>
<valueCodeableConcept>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-other-characteristics-packaged-item"/>
<code value="756005041001"/>
<display value="Modal-Packung"/>
</coding>
</valueCodeableConcept>
</characteristic>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="http://example.org/RegulatedAuthorisation/MA-67719001"/>
<resource>
<RegulatedAuthorization>
<id value="MA-67719001"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-regulatedauthorization"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_MA-67719001"> </a><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization MA-67719001</b></p><a name="MA-67719001"> </a><a name="hcMA-67719001"> </a><a name="MA-67719001-en-US"> </a><p><b>identifier</b>: <code>http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MarketingAuthorisationNumber</code>/67719001</p><p><b>subject</b>: <a href="PackagedProductDefinition-PMP-Cuprior-150mg-Filmcoatedtablet.html">PackagedProductDefinition: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-PCID#CH-7640109110007-6771901-001; description = CUPRIOR Filmtabl 150 mg 72 Stk</a></p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type 756000002001}">Marketing Authorisation</span></p><p><b>region</b>: <span title="Codes:{urn:iso:std:iso:3166 CH}">Switzerland</span></p><p><b>status</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status Z}">zugelassen</span></p><p><b>statusDate</b>: 2021-01-21</p><p><b>holder</b>: <a href="#hcMA-67719001/holder-Curatis-AG">Organization Curatis AG</a></p><p><b>regulator</b>: <a href="#hcMA-67719001/regulator-SMC">Organization SMC</a></p><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #holder-Curatis-AG</b></p><a name="MA-67719001/holder-Curatis-AG"> </a><a name="hcMA-67719001/holder-Curatis-AG"> </a><a name="MA-67719001/holder-Curatis-AG-en-US"> </a><p><b>identifier</b>: <code>urn:oid:1.2.276.0.76</code>/100082791, <a href="https://www.gs1.org/standards/id-keys/gln" title="Global Location Number">GLN</a>/7640109110007</p><p><b>name</b>: Curatis AG</p></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #regulator-SMC</b></p><a name="MA-67719001/regulator-SMC"> </a><a name="hcMA-67719001/regulator-SMC"> </a><a name="MA-67719001/regulator-SMC-en-US"> </a><p><b>identifier</b>: <code>urn:oid:1.2.276.0.76</code>/100010911, <a href="https://www.gs1.org/standards/id-keys/gln" title="Global Location Number">GLN</a>/7601001398511</p><p><b>name</b>: SMC</p></blockquote></div>
</text>
<contained>
<Organization>
<id value="holder-Curatis-AG"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-epl-organization"/>
</meta>
<identifier>
<system value="urn:oid:1.2.276.0.76"/>
<value value="100082791"/>
</identifier>
<identifier>
<system value="urn:oid:2.51.1.3"/>
<value value="7640109110007"/>
</identifier>
<name value="Curatis AG"/>
</Organization>
</contained>
<contained>
<Organization>
<id value="regulator-SMC"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-epl-organization"/>
</meta>
<identifier>
<system value="urn:oid:1.2.276.0.76"/>
<value value="100010911"/>
</identifier>
<identifier>
<system value="urn:oid:2.51.1.3"/>
<value value="7601001398511"/>
</identifier>
<name value="SMC"/>
</Organization>
</contained>
<identifier>
<system
value="http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MarketingAuthorisationNumber"/>
<value value="67719001"/>
</identifier>
<subject>🔗
<reference
value="PackagedProductDefinition/PMP-Cuprior-150mg-Filmcoatedtablet"/>
</subject>
<type>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type"/>
<code value="756000002001"/>
<display value="Marketing Authorisation"/>
</coding>
</type>
<region>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="CH"/>
<display value="Switzerland"/>
</coding>
</region>
<status>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status"/>
<code value="Z"/>
<display value="zugelassen"/>
</coding>
</status>
<statusDate value="2021-01-21"/>
<holder>
<reference value="#holder-Curatis-AG"/>
</holder>
<regulator>
<reference value="#regulator-SMC"/>
</regulator>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl value="http://example.org/RegulatedAuthorisation/FOPH-21208"/>
<resource>
<RegulatedAuthorization>
<id value="FOPH-21208"/>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_FOPH-21208"> </a><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization FOPH-21208</b></p><a name="FOPH-21208"> </a><a name="hcFOPH-21208"> </a><a name="FOPH-21208-en-US"> </a><blockquote><p><b>CH - EPL Reimbursement SL</b></p><ul><li>FOPHDossierNumber: <code>urn:oid:2.16.756.1</code>/21208</li><li>status: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-reimbursement-status 756001021001}">Reimbursed</span></li><li>statusDate: 2021-08-01</li><li>listingStatus: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-listing-status 756001002001}">Listed</span></li><li>listingPeriod: 2021-08-01 --> (ongoing)</li><li>firstListingDate: 2021-08-01</li><li>costShare: 10</li><li>gamme: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-gamme 756002004001}">Oral</span></li></ul></blockquote><blockquote><p><b>CH - EPL Product Price</b></p><ul><li>value: <span title="Swiss Franc">CHF3,022.10</span> (CHF)</li><li>type: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type 756002005002}">Ex-factory price</span></li><li>changeType: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change 756002006007}">Price mutation after triennal review of pharmaceuticals</span></li><li>changeDate: 2024-01-01</li></ul></blockquote><blockquote><p><b>CH - EPL Product Price</b></p><ul><li>value: <span title="Swiss Franc">CHF3,347.10</span> (CHF)</li><li>type: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type 756002005001}">Retail price</span></li><li>changeType: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change 756002006005}">VAT-change</span></li><li>changeDate: 2024-01-01</li></ul></blockquote><p><b>subject</b>: <a href="PackagedProductDefinition-PMP-Cuprior-150mg-Filmcoatedtablet.html">PackagedProductDefinition: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-PCID#CH-7640109110007-6771901-001; description = CUPRIOR Filmtabl 150 mg 72 Stk</a></p><p><b>type</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type 756000002003}">Reimbursement SL</span></p><h3>Indications</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Extension</b></td><td><b>Reference</b></td></tr><tr><td style="display: none">*</td><td/><td><a href="ClinicalUseDefinition-IND-10061091.html">ClinicalUseDefinition: type = indication</a></td></tr></table><p><b>holder</b>: <a href="#hcFOPH-21208/holder-Curatis-AG">Organization Curatis AG</a></p><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #holder-Curatis-AG</b></p><a name="FOPH-21208/holder-Curatis-AG"> </a><a name="hcFOPH-21208/holder-Curatis-AG"> </a><a name="FOPH-21208/holder-Curatis-AG-en-US"> </a><p><b>identifier</b>: <code>urn:oid:1.2.276.0.76</code>/100082791, <a href="https://www.gs1.org/standards/id-keys/gln" title="Global Location Number">GLN</a>/7640109110007</p><p><b>name</b>: Curatis AG</p></blockquote></div>
</text>
<contained>
<Organization>
<id value="holder-Curatis-AG"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-epl-organization"/>
</meta>
<identifier>
<system value="urn:oid:1.2.276.0.76"/>
<value value="100082791"/>
</identifier>
<identifier>
<system value="urn:oid:2.51.1.3"/>
<value value="7640109110007"/>
</identifier>
<name value="Curatis AG"/>
</Organization>
</contained>
<extension
url="http://fhir.ch/ig/ch-epl/StructureDefinition/reimbursementSL">
<extension url="FOPHDossierNumber">
<valueIdentifier>
<system value="urn:oid:2.16.756.1"/>
<value value="21208"/>
</valueIdentifier>
</extension>
<extension url="status">
<valueCodeableConcept>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-reimbursement-status"/>
<code value="756001021001"/>
<display value="Reimbursed"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="statusDate">
<valueDate value="2021-08-01"/>
</extension>
<extension url="listingStatus">
<valueCodeableConcept>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-listing-status"/>
<code value="756001002001"/>
<display value="Listed"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="listingPeriod">
<valuePeriod>
<start value="2021-08-01"/>
</valuePeriod>
</extension>
<extension url="firstListingDate">
<valueDate value="2021-08-01"/>
</extension>
<extension url="costShare">
<valueInteger value="10"/>
</extension>
<extension url="gamme">
<valueCodeableConcept>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-gamme"/>
<code value="756002004001"/>
<display value="Oral"/>
</coding>
</valueCodeableConcept>
</extension>
</extension>
<extension
url="http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice">
<extension url="value">
<valueMoney>
<value value="3022.1"/>
<currency value="CHF"/>
</valueMoney>
</extension>
<extension url="type">
<valueCodeableConcept>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type"/>
<code value="756002005002"/>
<display value="Ex-factory price"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="changeType">
<valueCodeableConcept>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change"/>
<code value="756002006007"/>
<display
value="Price mutation after triennal review of pharmaceuticals"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="changeDate">
<valueDate value="2024-01-01"/>
</extension>
</extension>
<extension
url="http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice">
<extension url="value">
<valueMoney>
<value value="3347.1"/>
<currency value="CHF"/>
</valueMoney>
</extension>
<extension url="type">
<valueCodeableConcept>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type"/>
<code value="756002005001"/>
<display value="Retail price"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="changeType">
<valueCodeableConcept>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change"/>
<code value="756002006005"/>
<display value="VAT-change"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="changeDate">
<valueDate value="2024-01-01"/>
</extension>
</extension>
<subject>🔗
<reference
value="PackagedProductDefinition/PMP-Cuprior-150mg-Filmcoatedtablet"/>
</subject>
<type>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type"/>
<code value="756000002003"/>
<display value="Reimbursement SL"/>
</coding>
</type>
<indication>
<extension
url="http://fhir.ch/ig/ch-epl/StructureDefinition/regulatedAuthorization-limitation">
<extension url="status">
<valueCodeableConcept>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-limitationstatus"/>
<code value="756002071001"/>
<display value="Limitation Reimbursed"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="statusDate">
<valueDate value="2021-08-01"/>
</extension>
<extension url="period">
<valuePeriod>
<start value="2021-08-01"/>
</valuePeriod>
</extension>
<extension url="firstLimitationDate">
<valueDate value="2021-08-01"/>
</extension>
<extension url="indicationCode">
<valueString value="ABCDE.XX"/>
</extension>
<extension url="limitationIndication">
<valueReference>🔗
<reference value="ClinicalUseDefinition/LIM-79886009"/>
</valueReference>
</extension>
<extension
url="http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice">
<extension url="value">
<valueMoney>
<value value="3022.1"/>
<currency value="CHF"/>
</valueMoney>
</extension>
<extension url="type">
<valueCodeableConcept>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type"/>
<code value="756002005002"/>
<display value="Ex-factory price"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="changeType">
<valueCodeableConcept>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change"/>
<code value="756002006007"/>
<display
value="Price mutation after triennal review of pharmaceuticals"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="changeDate">
<valueDate value="2024-01-01"/>
</extension>
</extension>
<extension
url="http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice">
<extension url="value">
<valueMoney>
<value value="3347.1"/>
<currency value="CHF"/>
</valueMoney>
</extension>
<extension url="type">
<valueCodeableConcept>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type"/>
<code value="756002005001"/>
<display value="Retail price"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="changeType">
<valueCodeableConcept>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change"/>
<code value="756002006005"/>
<display value="VAT-change"/>
</coding>
</valueCodeableConcept>
</extension>
<extension url="changeDate">
<valueDate value="2024-01-01"/>
</extension>
</extension>
</extension>
<reference>🔗
<reference value="ClinicalUseDefinition/IND-10061091"/>
</reference>
</indication>
<holder>
<reference value="#holder-Curatis-AG"/>
</holder>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl
value="http://example.org/ManufacturedItemDefinition/MI-Trientinum-150mg-Filmcoatedtablet"/>
<resource>
<ManufacturedItemDefinition>
<id value="MI-Trientinum-150mg-Filmcoatedtablet"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-manufactureditemdefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ManufacturedItemDefinition_MI-Trientinum-150mg-Filmcoatedtablet"> </a><p class="res-header-id"><b>Generated Narrative: ManufacturedItemDefinition MI-Trientinum-150mg-Filmcoatedtablet</b></p><a name="MI-Trientinum-150mg-Filmcoatedtablet"> </a><a name="hcMI-Trientinum-150mg-Filmcoatedtablet"> </a><a name="MI-Trientinum-150mg-Filmcoatedtablet-en-US"> </a><p><b>status</b>: Active</p><p><b>manufacturedDoseForm</b>: <span title="Codes:{urn:oid:0.4.0.127.0.16.1.1.2.1 10221000}">Film-coated tablet</span></p><p><b>unitOfPresentation</b>: <span title="Codes:{urn:oid:0.4.0.127.0.16.1.1.2.1 15054000}">Tablet</span></p></div>
</text>
<status value="active"/>
<manufacturedDoseForm>
<coding>
<system value="urn:oid:0.4.0.127.0.16.1.1.2.1"/>
<code value="10221000"/>
<display value="Film-coated tablet"/>
</coding>
</manufacturedDoseForm>
<unitOfPresentation>
<coding>
<system value="urn:oid:0.4.0.127.0.16.1.1.2.1"/>
<code value="15054000"/>
<display value="Tablet"/>
</coding>
</unitOfPresentation>
</ManufacturedItemDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="http://example.org/AdministrableProductDefinition/PhP-Trientinum-150mg-Filmcoatedtablet"/>
<resource>
<AdministrableProductDefinition>
<id value="PhP-Trientinum-150mg-Filmcoatedtablet"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-administrableproductdefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="AdministrableProductDefinition_PhP-Trientinum-150mg-Filmcoatedtablet"> </a><p class="res-header-id"><b>Generated Narrative: AdministrableProductDefinition PhP-Trientinum-150mg-Filmcoatedtablet</b></p><a name="PhP-Trientinum-150mg-Filmcoatedtablet"> </a><a name="hcPhP-Trientinum-150mg-Filmcoatedtablet"> </a><a name="PhP-Trientinum-150mg-Filmcoatedtablet-en-US"> </a><p><b>status</b>: Active</p><p><b>formOf</b>: <a href="MedicinalProductDefinition-Cuprior-150mg-Filmcoatedtablet.html">MedicinalProductDefinition: extension = Film-coated tablet,CUPRIOR wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden.; identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID#CH-7640109110007-6771901; domain = Human; indication = Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie.; legalStatusOfSupply = Abgabe auf ärztliche oder tierärztliche Verschreibung (B); classification = gilteritinib,Synthetika</a></p><p><b>administrableDoseForm</b>: <span title="Codes:{urn:oid:0.4.0.127.0.16.1.1.2.1 10221000}">Film-coated tablet</span></p><p><b>unitOfPresentation</b>: <span title="Codes:{urn:oid:0.4.0.127.0.16.1.1.2.1 15054000}">Tablet</span></p><h3>RouteOfAdministrations</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{urn:oid:0.4.0.127.0.16.1.1.2.1 20053000}">Oral use</span></td></tr></table></div>
</text>
<status value="active"/>
<formOf>🔗
<reference
value="MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet"/>
</formOf>
<administrableDoseForm>
<coding>
<system value="urn:oid:0.4.0.127.0.16.1.1.2.1"/>
<code value="10221000"/>
<display value="Film-coated tablet"/>
</coding>
</administrableDoseForm>
<unitOfPresentation>
<coding>
<system value="urn:oid:0.4.0.127.0.16.1.1.2.1"/>
<code value="15054000"/>
<display value="Tablet"/>
</coding>
</unitOfPresentation>
<routeOfAdministration>
<code>
<coding>
<system value="urn:oid:0.4.0.127.0.16.1.1.2.1"/>
<code value="20053000"/>
<display value="Oral use"/>
</coding>
</code>
</routeOfAdministration>
</AdministrableProductDefinition>
</resource>
</entry>
<entry>
<fullUrl value="http://example.org/Ingredient/Trientinum150"/>
<resource>
<Ingredient>
<id value="Trientinum150"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-ingredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="Ingredient_Trientinum150"> </a><p class="res-header-id"><b>Generated Narrative: Ingredient Trientinum150</b></p><a name="Trientinum150"> </a><a name="hcTrientinum150"> </a><a name="Trientinum150-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="AdministrableProductDefinition-PhP-Trientinum-150mg-Filmcoatedtablet.html">AdministrableProductDefinition: status = active; administrableDoseForm = Film-coated tablet; unitOfPresentation = Tablet</a></li><li><a href="ManufacturedItemDefinition-MI-Trientinum-150mg-Filmcoatedtablet.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Film-coated tablet; unitOfPresentation = Tablet</a></li></ul><p><b>role</b>: <span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-ingredient-role WIRKS}">Wirkstoff</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-substance SJ76Y07H5F}">Trientine</span></td></tr></table><h3>Strengths</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Presentation[x]</b></td></tr><tr><td style="display: none">*</td><td>150 mg<span style="background: LightGoldenRodYellow"> (Details: UCUM codemg = 'mg')</span>/1 Tablet<span style="background: LightGoldenRodYellow"> (Details: EDQM - Standard Terms code15054000 = 'Tablet')</span></td></tr></table></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="AdministrableProductDefinition/PhP-Trientinum-150mg-Filmcoatedtablet"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/MI-Trientinum-150mg-Filmcoatedtablet"/>
</for>
<role>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-ingredient-role"/>
<code value="WIRKS"/>
<display value="Wirkstoff"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-substance"/>
<code value="SJ76Y07H5F"/>
<display value="Trientine"/>
</coding>
</concept>
</code>
<strength>
<presentationRatio>
<numerator>
<value value="150"/>
<unit value="mg"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="Tablet"/>
<system value="urn:oid:0.4.0.127.0.16.1.1.2.1"/>
<code value="15054000"/>
</denominator>
</presentationRatio>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<fullUrl value="http://example.org/ClinicalUseDefinition/IND-10061091"/>
<resource>
<ClinicalUseDefinition>
<id value="IND-10061091"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-clinicalusedefinition-indication"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_IND-10061091"> </a><p class="res-header-id"><b>Generated Narrative: ClinicalUseDefinition IND-10061091</b></p><a name="IND-10061091"> </a><a name="hcIND-10061091"> </a><a name="IND-10061091-en-US"> </a><p><b>type</b>: Indication</p><p><b>subject</b>: <a href="MedicinalProductDefinition-Cuprior-150mg-Filmcoatedtablet.html">MedicinalProductDefinition: extension = Film-coated tablet,CUPRIOR wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden.; identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID#CH-7640109110007-6771901; domain = Human; indication = Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie.; legalStatusOfSupply = Abgabe auf ärztliche oder tierärztliche Verschreibung (B); classification = gilteritinib,Synthetika</a></p><blockquote><p><b>indication</b></p><h3>DiseaseSymptomProcedures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://www.meddra.org 10061091}">Wilson's disease</span></td></tr></table><h3>IntendedEffects</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{urn:oid:1.2.276.0.76 200000003194}">therapeutic</span></td></tr></table></blockquote></div>
</text>
<type value="indication"/>
<subject>🔗
<reference
value="MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet"/>
</subject>
<indication>
<diseaseSymptomProcedure>
<concept>
<coding>
<system value="https://www.meddra.org"/>
<code value="10061091"/>
<display value="Wilson's disease"/>
</coding>
</concept>
</diseaseSymptomProcedure>
<intendedEffect>
<concept>
<coding>
<system value="urn:oid:1.2.276.0.76"/>
<code value="200000003194"/>
<display value="therapeutic"/>
</coding>
</concept>
</intendedEffect>
</indication>
</ClinicalUseDefinition>
</resource>
</entry>
<entry>
<fullUrl value="http://example.org/ClinicalUseDefinition/LIM-79886009"/>
<resource>
<ClinicalUseDefinition>
<id value="LIM-79886009"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ClinicalUseDefinition_LIM-79886009"> </a><p class="res-header-id"><b>Generated Narrative: ClinicalUseDefinition LIM-79886009</b></p><a name="LIM-79886009"> </a><a name="hcLIM-79886009"> </a><a name="LIM-79886009-en-US"> </a><p><b>type</b>: Indication</p><blockquote><p><b>indication</b></p><h3>DiseaseSymptomProcedures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://snomed.info/sct 79886009}">Disorder of copper metabolism</span></td></tr></table><h3>IntendedEffects</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{urn:oid:1.2.276.0.76 200000003194}">therapeutic</span></td></tr></table></blockquote></div>
</text>
<type value="indication"/>
<indication>
<diseaseSymptomProcedure>
<concept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="79886009"/>
<display value="Disorder of copper metabolism"/>
</coding>
</concept>
</diseaseSymptomProcedure>
<intendedEffect>
<concept>
<coding>
<system value="urn:oid:1.2.276.0.76"/>
<code value="200000003194"/>
<display value="therapeutic"/>
</coding>
</concept>
</intendedEffect>
</indication>
</ClinicalUseDefinition>
</resource>
</entry>
</Bundle>